Posts By Alex
-
715Wire StoriesNTT Solmare: Obey Me!, the Mobile Game With Over 6 Million Downloads Across 186 Countries and Regions, Receives a Manga Adaptation
� Obey Me! The Comic is now available exclusively in Japan and the US OSAKA, Japan–(BUSINESS WIRE)–#NTTsolmare–NTT Solmare Corporation is pleased to...
-
496Wire Stories
Trio-Tech Resumes Operations at Tianjin City Facility
VAN NUYS, Calif.–(BUSINESS WIRE)–Trio-Tech International (NYSE MKT: TRT) today announced that it has resumed full operations at the Company�s Tianjin, China, facility....
-
577Wire Stories
NUAIR and PABLO AIR to Collaborate on Drone Delivery Solutions
INCHEON, South Korea–(BUSINESS WIRE)–#AirTrafficManagement—PABLO AIR, South Korea-based drone service provider, has signed a memorandum of understanding (MOU) with Northeast UAS Airspace Integration...
-
542Wire StoriesEXL named a Leader and Star Performer in Everest Group�s 2022 Life and Pensions Insurance BPS/TPA PEAK Matrix� Assessment
NEW YORK, Jan. 24, 2022 (GLOBE NEWSWIRE) — EXL [NASDAQ: EXLS], a leading global analytics and digital solutions company, announced today that...
-
537Wire Stories
Fair Go Casino: Magic Mike Pockets a Monster Win of Over $23,000
One lucky player wins big after December deposit SYDNEY–(BUSINESS WIRE)–It was a very happy Christmas for one lucky Fair Go Casino player,...
-
590Wire Stories
Grab Announces Investor Call Hosted by Evercore ISI
SINGAPORE–(BUSINESS WIRE)–Grab Holdings Limited, (NASDAQ: GRAB), announces a fireside chat hosted by Mark Mahaney from Evercore ISI on Wednesday, January 26, 2022...
-
593Wire Stories
ENDRA Life Sciences Expands into China with Shanghai General Hospital Partnership
TAEUS clinical study to serve as gateway for ENDRA into Asia�s largest healthcare market ANN ARBOR, Mich.–(BUSINESS WIRE)–$NDRA #NAFLD—ENDRA Life Sciences Inc....
-
526Wire StoriesGilat and Intelsat Expand Their Strategic Partnership in Commercial Aviation
Gilat technology for in-flight connectivity will empower expansion of in-flight service in Asia and meet the post-COVID demand for commercial and business...
-
727Wire Stories
Ranok Therapeutics Announces U.S. FDA Clearance to Proceed With Its First-in-Human Trial of RNK05047 in Patients With Advanced Solid Tumor Cancers and Lymphomas (CHAMP-1)
–An important milestone for the first protein degrader developed using Ranok�s innovative CHAMP� technology, with clinical enrollment expected to begin in the...
-
611Wire Stories
EdiGene Enters Strategic R&D Collaboration with Haihe Laboratory of Cell Ecosystem to Develop Hematopoietic Stem Cell Regenerative Therapies and Platform Technologies
BEIJING & CAMBRIDGE, Mass.–(BUSINESS WIRE)–EdiGene, Inc., a global biotechnology company focused on translating gene-editing technologies into transformative therapies for patients with serious...
